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Intermittent claudication is a symptom of atherosclerosis of the lower limbs (peripheral arterial disease (PAD)) and is char-
acterized by pain and cramps of lower limb muscles during exercise. Claudication leads to a reduction in physical activity of
patients. PAD is a systemic disease. Atherosclerotic lesions located in the arteries of the lower limbs not only pose the risk of the
ischemic limb loss, but above all, they are an important prognostic factor. Patients with claudication are at significant risk of
cardiovascular complications such as infarcts or strokes. Comprehensive rehabilitation of patients with intermittent claudication
based on the current TASC II (Inter-Society Consensus for the Management of Peripheral Arterial Disease) guidelines, ESC
(European Society of Cardiology) guidelines, and AHA (American Heart Association) guidelines includes supervised treadmill
training, training on a bicycle ergometer, NordicWalking, resistance exercises of lower limbmuscles, and exercises of upper limbs.
A trained, educated, and motivated patient has a chance to improve life quality as well as life expectancy.
1. Introduction
One of the most common causes of disease and death in the
Western world is atherosclerosis. *e process is charac-
terized by the formation of atherosclerotic plaques that
narrow the lumen of the arteries, and its clinical symptoms
depend on the location of the lesions. PAD prevalence
varies widely between countries, increases sharply with age,
and has a relation to ethnicity [1]. Atherosclerosis is
considered a systemic disease. It may present as coronary
artery disease, cerebrovascular disease, and renal artery
stenosis or peripheral arterial disease. *e latter disorder
(PAD) consists in narrowing and finally total occlusion of
the main vessels supplying the lower limbs [2]. *is results
in pain and disturbances in the economics of walking,
which limits the ability to ambulate and decreases physical
activity of the patients. Hence, it forms a significant
problem for the physiotherapist. *e rehabilitation is
complex. It must take into account not only the risk of
amputation of ischemic lower limbs and reduced quality of
life but above all the fact that limb ischemia is an important
prognostic factor of general cardiovascular complications
[3]. *erefore, kinesitherapy in patients with atheroscle-
rotic lower limb ischemia apart from rehabilitation of
locomotive disturbances must take into account the ele-
ments of cardiac rehabilitation [4].
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1.1. Intermittent Claudication. PAD often manifests as in-
termittent claudication. It is characterized by cramp and
pain of a given muscle group. Discomfort occurs only during
exercise and intensifies gradually as one continues to walk
until it forces complete stop. Effort-related lower limb
muscle pain is associated with transient ischemia (IIa and IIb
degrees of Fontaine classification). *e patient with in-
termittent claudication does not feel any discomfort at rest
because the blood flow and oxygen supply in the limb are
then replenished. During exercise, narrowed or occluded
arteries supplying the muscles of the lower limbs limit the
necessary increase in blood flow, which results in dispro-
portions between metabolic demand and oxygen supply and
is associated with the occurrence of claudication [5]. As a
result of muscle ischemia, anaerobic metabolic products are
released. Anaerobic glycolysis resulting from limited oxygen
supply is accompanied by the increase in lactic acid con-
centration and depletion of adenosine triphosphate (ATP)
and phosphocreatine stocks, causing pain [6]. *e symptom
of claudication, also called the symptom of “shop displays”
or “hungry muscle pain,” is so characteristic for PAD that
proper diagnosis of the disease can usually be made based
solely on properly collected anamnesis [7].
Intermittent claudication limits the locomotive abilities
and also makes it difficult for the patient to actively par-
ticipate in personal, social, and professional life and is one of
the causes of disability of middle-aged and elderly people [8].
Fontaine’s scale is used for staging of the atherosclerotic
disease of lower extremities. Absence of or minimal clinical
symptoms in the form of tingling, numbness, and cold
sensitivity define stage I. Stage IIa is intermittent claudi-
cation with the distance above 200m, whereas stage IIb is
below 200m. Stage III accounts for rest pain, and grade IV
comprises ulcers of gangrene and necrosis. Stages III and IV
are referred to as critical limb ischemia [9].
1.2. Evaluation of the Patient with PAD by the
Physiotherapist. *e basic examination of patients with
PAD consists of palpation of the pulse in the typical sites on
the lower limb, i.e., in the inguinal and popliteal regions and
dorsal region of the foot and medial ankle. *e lack of a
palpable pulse indicates a significant narrowing or occlusion
in the arterial system proximally to the examined area [10].
*ere are two determinants of the patient’s ability to
ambulate. *e maximal claudication distance (MCD) is
defined as the distance after which the patient is forced to
stop because of severe pain and muscle cramps. Another
one, i.e., pain-free walking distance (PFWD), is the distance
traveled before any pain occurs. A correctly estimated
distance is an important element in the decision of a vascular
surgeon or angiologist regarding further medical or surgical
treatment. A distance of about 100m and below prequalifies
the patient for invasive treatment [11].
*e degree of impairment of blood supply to the limb is
assessed by measurement of the ABI (ankle-brachial index).
*e ABI is expressed as the ratio of the systolic pressure
measured in the area of the ankle and the systolic pressure
measured in the arm. Under physiological conditions, the
ABI in the supine position is close to 0.9–1.4. In patients with
PAD, ABI values fall below 0.9, and below 0.4, it correlates
with critical limb ischemia [12]. It should however be re-
membered that, in a subgroup of patients with diabetes or
renal insufficiency, false negatives can be expected. It is due
to the so-called “stiffness” of small artery walls and their
resistance to compression [13, 14]. From the general health’s
point of view, the reduced ABI also correlates with car-
diovascular events. Chronic lower limb ischemia is closely
related to myocardial ischemic disease and cerebral artery
disease. An ABI less than or equal to 0.9 is associated with a
3- to 6-fold increase in the risk of cardiovascular mortality.
*is risk correlates with the ABI reduction rate—the lower
the ABI, the greater the risk [15].
*e latest findings of the European Society for Vascular
Medicine in May 2019 contained in the Second European
Agreement prove that classic PAD classifications are not
complete and evidence-based. *e need to define patients
with a high risk of amputation and to categorize the patients
whose prognosis improves owing to revascularization was
indicated. Measurement of systolic toe pressure (STP), with
a value below 30mmHg suggesting the need for re-
vascularization, appears to be an important factor. Patients
with STP above 30mmHg and suspected PAD should be
treated conservatively in specialized centers, and the need
for revascularization should be considered individually [16].
In physical examination, attention should be paid to
changes in the color of the skin, especially to the paleness
which increases after lifting the limb up. Long-lasting
chronic ischemia is indicated by hair loss, especially in the
case of unilateral ischemia as opposed to the healthy limb.
Additional features include thickened, deformed, slow-
growing nails with a tendency to fungal infections. Chronic
ischemia of the lower limbs is also characterized by muscular
atrophies affecting the muscles of the feet and shins. *e
Ratschow test is a useful adjunct to routine peripheral
vascular assessment and, if positive, suggests more severe
ischemia with distal limb artery involvement [17].
Location of the pain described by a patient may be useful
for determining the anatomical area of the lesion, which may
later facilitate diagnostic and therapeutic decisions. Clau-
dication affecting the buttocks and thighs, sometimes
combined with impotence, may be associated with stenosis
or occlusion within the bifurcation of the abdominal aorta
(Leriche’s syndrome). *e most frequent localization of
PAD is the superficial femoral artery, and its narrowing is
manifested by claudication within the calf. Exercise pain in
the foot usually indicates impairment of the calf arter-
ies—tibial anterior, tibial posterior, or sagittal (at least 2 of 3).
Lesions may also occur in multiple sections of the arterial
system, and it usually follows more advanced stage of ath-
erosclerosis [18].
2. Conservative Treatment
Physiotherapists can start working with the patient with
lower extremity PAD only if physical therapy is indicated by
the angiologist or vascular surgeon after the patient has been
diagnosed with lower extremity PAD; the location of the
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stenosis causing lower extremity ischemia has been detected;
the stage of chronic ischemia, the initial and absolute
claudication distances, and the type of treatment (phar-
macological or surgical) are determined; and coexisting
diseases and contraindications to specific rehabilitation
methods are known. An individual personalized outpatient
rehabilitation program should be designed for each patient.
2.1. Supervised Walking Training on the Treadmill. *e
current principles of atherosclerotic treatment of lower limb
ischemia are based on the 2007 TASC II (Inter-Society
Consensus for the Management of Peripheral Disease)
guidelines and the 2017 ESC (European Society of Cardi-
ology) guidelines, prepared in collaboration with the ESVS
(European Society for Vascular Surgery) [19, 20]. Treatment
of patients with intermittent claudication, especially with
distal occlusion, is mainly conservative therapy, the aim of
which is to improve the quality of life by relieving pain in the
limbs while walking, thereby increasing the distance of
claudication and reducing the risk of cardiovascular com-
plications. Intermittent claudication is by far a greater in-
dicator of cardiovascular risk than it is of the limb’s fate.
According to the literature, only 18% of patients with
claudication will require surgical intervention and 10% will
be amputated in a 10-year follow-up, while mortality from
infarcts and strokes at 5, 10, and 15 years will be 30%, 50%,
and 70%, respectively [21].
*e walking training is a very important element in the
conservative treatment of PAD, apart from pharmacother-
apy and the modification of risk factors, which include
smoking, lipid disorders, hypertension, diabetes, obesity,
and stress. In accordance with the ESC and TASC II
guidelines, the supervised training on a treadmill should be a
primary procedure in all patients with intermittent clau-
dication [22]. Training sessions should last 30 to 60minutes
and be run 3 times a week for a minimum of 3months. *e
proposed belt speed is 3.2 km/h with increasing inclination
of a treadmill. At the same time, it is emphasized that the
maximum pain of ischemic muscles during walking should
always be avoided [19, 20] (Figure 1). It remains a matter of
dispute whether during the march any muscle pain should
be allowed or not, considering the potentially unfavorable
aspects of the ischemia—reperfusion phenomenon, which
can lead to a generalized inflammatory reaction. *e
Gardner meta-analysis in 1995 focuses only on the benefits
of increasing the distance of claudication, suggesting that
walking training should be based on efforts conducted until
maximum or close to the maximum severity of pain [23].
*e current TASC II and the AHC (American Heart As-
sociation) and ESC guidelines suggest stopping the walking
session when the pain reaches the moderate intensity,
suggesting that if the patient stops at the onset of pain, the
response to the training will be inadequate [24]. At the same
time, TASC II strongly recommends avoiding the highest
level of pain. Supervised walking training on a treadmill is
the most effective form of rehabilitation of patients with
intermittent claudication and is a “gold standard.” More-
over, it is a safe method because it practically excludes the
risk of injuries or complications. *emechanism underlying
the increasing walking distance in patients with intermittent
claudication following exercise therapy is not clear. *is
effect is not based on one mechanism but results from a
combination of many factors. Authors of many publications
emphasize that treadmill walking causes beneficial rheo-
logical changes, causing increased deformability of eryth-
rocytes and decreased blood viscosity. It also leads to
morphological changes in muscle fibers, thanks to the im-
proved capillary flow. Finally, training changes the per-
ception of pain through increased supply of endorphins,
leads to so-called “walking economy” improvement, and
importantly causes pleiotropic changes in metabolism
[25–27].
Training on the treadmill can be gradually modified by
extending the duration from 30 to 60minutes as well as the
speed from 3.2 to 4.8 km/h [28]. Atherosclerotic changes in
arteries in patients with intermittent claudication are usually
global; that is, they may also affect the cerebral and cardiac
circulation. *erefore, treadmill exercises must take into
account both beneficial (the extension of the claudication
distance) and potential harmful effects on the cardiovascular
system. *e initial exercise test on the treadmill with mea-
surements of blood pressure (CTK), heart rate (CAS), and
ECG recording preceding long-term rehabilitation may allow
to rule out severe concomitant circulatory disorders and thus
avoid potential risk that a full, multiweek program of intense
treadmill exercise might pose to affected individuals [29, 30]
(Figure 2). Previously stated advanced unstable coronary
heart disease, ischemic neurological disorders, and some
muscular and joint disorders are also contraindications to
motor rehabilitation on the treadmill. *e percentage of
patients disqualified from physical rehabilitation according to
different tests varies from 7 to 34% [31, 32].
It should be noted that atherosclerosis is a systemic
problem and cardiac rehabilitation is refunded by the
Figure 1: Treatment of claudication: treadmill training.
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national health services. At the same time, rehabilitation of
patients with PAD in many countries is not eligible for
refund.
2.2. Unattended Forms of Walking Exercises. Physical ac-
tivity in patients with intermittent claudication is an integral
part of general treatment. Since 69% of eligible PAD patients
refuse to participate in supervised exercises 3 times a week
because they are too burdensome for them, it is extremely
important both to convince them about the purpose of
walking exercises and to skillfully introduce training in their
everyday activities [33]. In the literature, one can find papers
discussing the principles of everyday activities of patients
with claudication. It is assumed that the patient should walk
about 3–5 km a day or ride a bicycle 10 km, stopping at the
beginning of muscle pain, resting, and continuing training
until the next stop [34, 35]. In practice, however, the vast
majority of patients, instead of a detailed instruction on the
walking training, receive at most a general recommendation
“please do a lot of walking.” As the research shows, such a
vague recommendation from a vascular surgeon or family
physician, without explaining exactly what rules should be
followed in everyday walks, can also lead to patients walking
until maximum pain, which is inconsistent with the current
TASC II recommendations [22]. Going to the maximum
pain may precipitate adverse consequences and increases the
risk of cardiovascular complications. *erefore, among
patients with PAD, a safe “walk a lot, but not forcefully”
recommendation should be promoted instead of using the
wrong technique of “crying but walking” [36]. It should be
emphasized that if during the walk the patient feels severe
pain and muscle cramps, it causes highly adverse conse-
quences as a result of ischemia—reperfusion injury (IRI)
[37–39]. Restoration of the blood flow in severely ischemic
muscles transfers active neutrophils to the general circula-
tion with the subsequent release of active forms of oxygen
and nitrogen (free radicals). *ese compounds cause, inter
alia, the conversion of cholesterol into oxycholesterol, which
is easily captured by the walls of the arteries through the
scavenger receptor.*is phenomenon to a certain extent can
explain the rapid progression of atherosclerosis in patients
with claudication and their high mortality due to myocardial
infarction and stroke [8, 40].
On the contrary, it would also be a mistake to limit the
patient’s physical effort since the mere exchange of
10minutes of a sedentary lifestyle for 10minutes of low-
intensity physical activity reduces mortality by as much as
9% [41]. *e total exertion should consist of repeating
marches, preferably until the beginning of lower extremity
muscle pain, followed by rest. Maximum dilatation of ar-
terial vessels occurs before ischemic pain. *e advantage of
walking training at home arises from the ability to in-
dividualize the effort; however, it is also easier for less
disciplined patients to cease exercising without supervision.
At the same time, it is emphasized that training at home can
be as effective as outpatient treatment, provided that it is
periodically monitored, for example, by activity-monitoring
devices or by periodic checks every few days. Pain threshold
should be determined in hospitals/clinics, which should be
followed by discussion on activities that patient should
repeat at home [42, 43]. Patients over 60 years are recom-
mended to walk 60 steps per minute, whereas younger
patients can go up to 120 steps per minute. A rhythmic and
dynamic march is recommended. Slow walking is not rec-
ommended because part of the work is then used to stop, and
consequently, it is nonergonomic activity.*e gait should be
smooth, and the tendency to save the affected limb (stalling)
should be avoided. It is good when the march takes place on
a moderately hard surface, preferably along a path in the
park. If, of necessity, training is carried out on hard pave-
ments, comfortable, airy footwear on a thick flexible sole is
recommended. Duration of marching training should not
exceed 20minutes in the initial period, and later, it could be
extended to 45minutes. Training should be repeated 2-3
times a day. Patients with a longer claudication distance can
be trained to climb stairs, which additionally involves crural
and sciatic muscles [44]. Walking training can also be
conducted in the form of Nordic Walking, where swinging
symmetrical movements of the upper limbs are performed in
a rhythmic walk with poles [45]. One of the recommended
special forms of exercises is Buerger’s training consisting in
alternating exercises in the position of (1) ischemia, (2)
congestion, and (3) relaxation of the muscles of the lower
limbs [46].
2.3. Training on a Bicycle Ergometer. In the rehabilitation of
patients with PAD, cycling and exercises on a bicycle er-
gometer (stationary bike) or a rehabilitation rotor, i.e., a
device for exercising the lower limb muscles in a sitting
position, are also used.*ese activities are particularly useful
for patients who for some reason have limitations in con-
ducting walking training, for example, degenerative joint
Figure 2: Exercise test on the treadmill with blood pressure (CTK),
heart rate (CAS), and ECG monitoring.
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changes in the lower limbs, neurological disorders, or ex-
cessive body weight. Because exercises on a bicycle er-
gometer with a comparable load increase the activity of the
proximal muscle groups of the limb, while the march causes
the load on the distal muscles—mainly calves, it is important
that the patient places his forefoot, instead of the midfoot or
the heel, on the pedal, which will allow for greater crural
muscle involvement during exercise. If a patient is riding a
bicycle or pressing the rotor pedals, it is not meant to make
him or her breathless or evoke pain in the ischemic muscles
of the lower limbs. Safe training on painless distances or
until a small pain sensation interspersed with a few minutes
of rest is recommended instead. *e patient will benefit the
most if the training is run every day and if the total distance
covered about 10 km. *e appropriately chosen load should
be based on the result of an exercise test with CTK, CAS, and
ECG recording, prior to the rehabilitation [24, 47].
2.4. Exercises of Upper Limbs. Training of upper arms (arm
cranking) can be a highly beneficial procedure in patients
with lower limb claudication according to some papers. It is
suggested that improvement of cardiovascular endurance
may contribute to improving gait. It has been demonstrated
that exercises of upper limbs increase the antioxidant po-
tential and lead to the extension of painless and maximum
distance of claudication. Certainly, it can also be expected
that this form of training contributes to strengthening the
muscles of the upper limbs, possible blood pressure nor-
malization, and improvements in the circulatory system as a
whole [48–50].*e load should be chosen regarding optimal
conditions for cardiovascular training. It is described as the
physical fitness zone—defined as 50–75% of the maximum
heart rate (220 − age). *is range is considered to be the
target heart rate during exercise. Exceeding this limit might
pose a risk to the myocardium [51–53]. Patients with PAD
who poorly tolerate walking or have a limited ability to
perform lower limb exercises would benefit most from this
form of activity.
2.5. Physical Medicine. Physical therapy is also used in the
treatment of patients with intermittent claudication. It is not
an isolated form of therapy but rather an accessory element
of therapeutic regimen with primarily hyperemic, vaso-
dilating, and analgesic and anti-inflammatory effects. *is
applies particularly to patients’ concomitant conditions such
as degenerative changes of the joints of the lower limbs, in
which the ability of walking is deteriorated. *ese methods
can also provide the patients with a preparatory element for
muscle and joint kinesitherapy, as they result in tissue re-
laxation [54]. Previous studies are not conclusive as far as the
efficiency of physiotherapeutic methods for increasing the
distance of claudication or improving collateral circulation is
concerned. Nonetheless, physiotherapy as adjunctive and
complementary treatment in IIa/b limb ischemia in the
Fontaine classification seems to be beneficial. It is worth
noting, however, that because of the possible sensory dis-
orders accompanying ischemia, the use of currents or
thermal procedures should be carefully considered, so as not
to cause burns [55].
*e vasodilatation is achieved through the use of mag-
netotherapy, galvanic current, iontophoresis, Bernard’s dia-
dynamic currents, TENS, Träbert currents, and interference
currents. *e effect can also be obtained using infrared ra-
diation, ultrasounds, and therapeutic baths, preferably carbon
acid, radium, sulfide and hydrogen-sulfide, or brine [56].
*e beneficial effect of tissue overheating on patients
with obliterative atherosclerosis of the lower limb arteries is
associated with an increase in blood flow. It can be achieved
by means of infrared radiation of the Sollux lamp. *ese
treatments also lead to relaxation of contractured muscles,
joints, ligaments, and tendons.
In order to induce contraction of specific muscles,
electrostimulation with electric impulses or Wadit high-
frequency therapy is used for their stimulation. *is type of
electrogymnastics can be used in the treatment of muscular
atrophy and muscular weakness, for example, in patients
with short claudication distance [57].
*e effect of biostimulation of microcirculation leading
to restoration of the network of damaged blood vessels,
improvement of the rheological properties of blood, and
increased production of collagen by fibroblasts is observed
during polarized light therapy. *is speaks for the potential
use of this physiotherapeutic method in the treatment of
patients with intermittent claudication [58].
Analgesic and anti-inflammatory effects on muscles,
joints, tendons, and nerves are obtained, thanks to the use of
electrotherapy, including galvanic current and iontopho-
resis, diadynamic currents, interference currents, TENS,
short-wave diathermy, and magnetotherapy. Light therapy
with analgesic effects includes laser therapy, piler polarized
light, and infrared radiation—Sollux lamp. Ultrasounds give
a similar therapeutic effect [59].
*e Kneipp method is used to reduce the activity of the
vasomotor nerves resulting from regulation of the auto-
nomic nervous system centers. *is particular form of
balneotherapeutic treatment in the case of atherosclerosis of
the lower limbs is based on the comprehensive use of hy-
drotherapy (mainly Hauffe showers and baths), therapeutic
use of physical activity, learning health-related lifestyle,
phytotherapy, and mental hygiene. Exercises in water, in
particular swimming, have a beneficial effect on the function
of the heart and peripheral vessels. Faster circulation of
blood contributes to better supply of tissues and organs with
oxygen and nutrients and increases the exercise tolerance of
the human body [60, 61].
3. Invasive Treatment
Endovascular or surgical invasive treatment is indicated only
in a subgroup of patients with atherosclerotic lower limb
ischemia, in whom motor rehabilitation and conservative
treatment did not bring the expected improvement and in
the subjects with critical limb ischemia due to the risk of
amputation and even death. Generally, it is assumed that
invasive treatment is undertaken when the distance of
claudication is 100m and below, as well as in the patients
BioMed Research International 5
with resting pain and necrotic changes (III and IV degrees of
Fontaine classification). *e degree of impairment of the
patient’s mobility and quality of life, the anatomical location
of atherosclerotic lesions, the expected immediate and re-
mote benefits of treatment, and the risk of complications are
the most important factors in the choice of therapeutic
modality [62]. *ere are multiple scientific studies which
show that a rigorous program of supervised exercise can
be in the long term just as beneficial as angiosurgical
treatment and is more effective than angioplasty [63]
(Figure 3).
Percutaneous transluminal angioplasty (PTA) is an in-
travascular procedure and involves the widening of the
narrowed or even occluded artery lumen. Very often, the
stent implantation or the introduction of a specific “scaf-
folding” is an extension of balloon angioplasty. It is used to
prolong the patency of the vessel after angioplasty and
“hold” the atherosclerotic plaque or treat the dissection of
the artery following ballooning.
Respiratory and antithrombotic exercises of lower legs,
consisting in activation of the calf muscle pump, are a
routine element of prophylaxis for hospitalized patients
and constitute a valuable supplement to the rehabilitation
of patients after endovascular procedures. Initially, the
exercises involving the hip joint or the area of the puncture
site (usually the femoral artery) are avoided so that the
hematoma does not develop [64]. After the re-
vascularization procedure, the inflow of blood to the limb
improves significantly, resulting in limb warming, increase
in the ankle-arm index, elongation of painless and maximal
walking distance, reduction of rest pain, and quality of life
improvement. Endovascular procedures must be followed
with auxiliary measures, that is, intake of antiplatelet or
antiaggregating drugs and cholesterol-normalizing drugs
and normalization of blood pressure and blood glucose
levels [20]. Not only systematic pharmacotherapy but also
adequate physical activity and nicotine abstinence are
necessary to maintain long-term treatment results. Pro-
coagulative effects of smoking significantly increase the risk
of reocclusion of the treated artery, and loss of the limbmay
follow. Physical activity recommendations after endovas-
cular surgery and hospital discharge are akin to these for
the patients with intermittent claudication and mainly
involve walking training 3–5 km per day consisting of
several stages followed by rest when low-intensity pain
occurs [65]. A 6-minute test or a hall-walk test is the
simplest measure for the assessment of the claudication
distance (both PFWD and MCD) increase after arterial
repair and rehabilitation. It is believed that the exertion
during this examination is more representative of daily
activities compared to other forms of distance assessment,
e.g., a treadmill test [66, 67].
Stage I
intermittent
claudication
Stages IIa and IIb Stage III Stage IV
Initial 3 months of 
conservative treatment
Surgical
endovascular revascularisation
Limb amputation
Risk factor
modification
Physiotherapy
Supervised and 
unattended walking
training
(i)
(ii) Nordic Walking
(iii) Bicycle ergometer 
training
Pharmacotherapy
Reevaluation
Clinical 
improvement
Worsening of
symptoms
claudication 
distance <100m
Continuation of
conservative treatment
PAD diagnosis
Figure 3: Management of PAD.
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4. Therapeutic Education
Proper education of patients with atherosclerosis of the lower
limbs should be a professional and individualized action and
cannot be based solely on spreading of the old Housley’s
principle “stop smoking and keep walking” [68].*e patient’s
conscious participation in the therapeutic process increases the
effectiveness of treatment. *e PAD patient should know that
correctly conducted, long-term training is an indispensable
element of therapy and that smoking is of great importance in
the development of atherosclerosis [69]. Nicotine stimulates the
adrenal medulla causing the secretion of catecholamines which
results in, among others, vasoconstriction, increase of peripheral
vascular resistance, and reduction of HDL (“good”) cholesterol.
Depending on the filter, cigarettesmay vary as far as amounts of
nicotine and tar components are concerned, but still, the carbon
monoxide generated by tobacco combustion has the most
significant damaging effects on the vascular endothelium. Its
amount generated during smoking is always the same, re-
gardless of cigarettes being “light” or “strong.” *e risk of
atherosclerosis increases with the amount of cigarettes smoked
and the time of smoking. *e mere cessation of smoking may
result in an increase in the distance of claudication by as much
as 40% [70]. *e introduction of a proper diet is an important
activity that should be carried out by patients with PAD. *e
most important purpose of nutritional regimen is to reduce
cholesterol, especially LDL cholesterol. Limitation of the intake
of saturated fatty acids contained especially in milk and meat
products is one of the preventivemeasures for lowering the level
of LDL and triglycerides and increasingHDL. At the same time,
the consumption of vegetable oils rich in unsaturated fatty acids
is recommended. Rapeseed oil, omega-6 fatty acid-rich sun-
flower or soybean oil, and omega-3-abundant linseed and
walnut oil are the examples [6]. Another preventive measure is
the supplementation of nitric oxide. It can be achieved by the
intake of nitrate-rich products, which then undergo reduction
to nitric oxide in vivo. A popular product rich in nitrates is beet
juice. It can be assumed that the combination of beet juice
intake and walking training would bring the greatest benefit to
patients with PAD [71].
Diabetes is an important risk factor for the development
and progression of PAD. Among diabetic patients, intermittent
claudication occurs 4 times more frequently, whereas gangrene
and limb amputation as a consequence peripheral athero-
sclerosis occur 15 times more often than in nondiabetic
subjects [64, 72]. *erefore, in these patients, besides main-
taining blood glucose within the recommended limits and the
use of individually selected physical exercises, education is
necessary. It includes regular feet inspection and hygiene,
proper toenail cutting, wearing appropriate footwear, insoles
and socks, and avoiding mechanical and thermal injuries [73].
5. Conclusions
PAD is a systemic disease. Symptomatic PAD not only poses
the risk to ischemic extremity, but above all, it is an im-
portant prognostic factor of general cardiovascular com-
plications. Rehabilitation of patients with intermittent
claudication should be a comprehensive, long-term action,
initiated from the moment of diagnosis. It should be in-
dividually matched to the patient’s capability. A trained and
motivated patient has a chance to improve both the life
quality and expectancy, which is why education of patients
with PAD is extremely important. Effective education
should be conducted not only by angiologists or vascular
surgeons but also by physiotherapists and nurses.
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